Centers for Disease Control and Prevention Centers for Disease Control and Prevention CDC Home Search CDC CDC Health Topics A-Z site search
National Office of Public Health Genomics
Centers for Disease Control and Prevention
Office of Genomics and Disease Prevention
Site Search

HuGENet Publications

Improving the Prediction of Complex Diseases by Testing for Multiple Disease‐Susceptibility Genes
Quanhe Yang,1, Muin J. Khoury,2, Lorenzo Botto,1, J. M. Friedman,4 and W. Dana Flanders3
Am J Hum Genet. 2003 Mar;72(3):636-49

line

References

  1. Albert A (1982) On the use and computation of likelihood ratios in clinical chemistry. Clin Chem 28:1113–1119
  2. Barber JC (1998) Code of practice and guidance on human genetic testing services supplied direct to the public. Advisory Committee on Genetic Testing. J Med Genet 35:443–445
  3. Beaudet AL (1999) 1998 ASHG presidential address: making genomic medicine a reality. Am J Hum Genet 64:1–13
  4. Bell J (1998) The new genetics in clinical practice. BMJ 316:618–620
  5. Botto LD, Khoury MJ (2001) Commentary: facing the challenge of gene‐environment interaction: the two‐by‐four table and beyond. Am J Epidemiol 153:1016–1020
  6. Breslow NE, Day NE, Davis W, Estève J, International Agency for Research on Cancer (1980) Statistical methods in cancer research. IARC Press, Lyon, France
  7. Collins FS (1999) Shattuck lecture—medical and societal consequences of the Human Genome Project. N Engl J Med 341:28–37
  8. Coughlin SS, Trock B, Criqui MH, Pickle LW, Browner D, Tefft MC (1992) The logistic modeling of sensitivity, specificity, and predictive value of a diagnostic test. J Clin Epidemiol 45:1–7
  9. Evans JP, Skrzynia C, Burke W (2001) The complexities of predictive genetic testing. BMJ 322:1052–1056
  10. Fagan TJ (1975) Letter: nomogram for Bayes theorem. N Engl J Med 293:257
  11. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879–1886
  12. Greenland S (1983) Tests for interaction in epidemiologic studies: a review and a study of power. Stat Med 2:243–251
  13. Guttmacher AE, Collins FS (2002) Genomic medicine: a primer. N Engl J Med 347:1512–1520
  14. Hansson PO, Welin L, Tibblin G, Eriksson H (1997) Deep vein thrombosis and pulmonary embolism in the general population. “The Study of Men Born in 1913.” Arch Intern Med 157:1665–1670
  15. Holtzman NA, Marteau TM (2000) Will genetics revolutionize medicine? N Engl J Med 343:141–144
  16. Holtzman NA, Murphy PD, Watson MS, Barr PA (1997) Predictive genetic testing: from basic research to clinical practice. Science 278:602–605
  17. Holtzman NA, Watson MS (eds) (1998) Promoting safe and effective genetic testing in the United States: final report of the task force on genetic testing. Johns Hopkins University Press, Baltimore
  18. Hosmer DW, Lemeshow S (1992) Confidence interval estimation of interaction. Epidemiology 3:452–456
  19. Kleinbaum DG (1998) Applied regression analysis and other multivariable methods. Duxbury Press, Pacific Grove, CA
  20. McCullagh P, Nelder JA (1989) Generalized linear models. Chapman and Hall, London
  21. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T (1992) A prospective study of the incidence of deep‐vein thrombosis within a defined urban population. J Intern Med 232:155–160
  22. Pennisi E (1999) DNA chips give new view of classic test. Science 283:17–18
  23. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33–36
  24. Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH (1997) Age‐specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med 126:528–531
  25. Sackett DL (1991) Clinical epidemiology: a basic science for clinical medicine. Little Brown, Boston
  26. Seligsohn U, Lubetsky A (2001) Genetic susceptibility to venous thrombosis. N Engl J Med 344:1222–1231
  27. Simel DL, Samsa GP, Matchar DB (1993) Likelihood ratios for continuous test results: making the clinicians' job easier or harder? J Clin Epidemiol 46:85–93
  28. Southern EM (1996) DNA chips: analysing sequence by hybridization to oligonucleotides on a large scale. Trends Genet 12:110–115
  29. Vineis P, Schulte P, McMichael AJ (2001) Misconceptions about the use of genetic tests in populations. Lancet 357:709–712
  30. Wald NJ, Leck I (2000) Antenatal and neonatal screening. Oxford University Press, New York
  31. White RH, Zhou H, Romano PS (1998) Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 128:737–740
Cited by
  1. Kung-Hao Liang, Ying-Jye Wu. (2007) Prediction of complex traits based on the epistasis of multiple haplotypes. Journal of Human Genetics 52:5, 456
  2. Kung-Hao Liang, Yuchi Hwang, Wan-Ching Shao, Ellson Y. Chen. (2006) An algorithm for model construction and its applications to pharmacogenomic studies. Journal of Human Genetics 51:9, 751
  3. Juan P. Casas, Jackie Cooper, George J. Miller, Aroon D. Hingorani, Steve E. Humphries. (2006) Investigating the Genetic Determinants of Cardiovascular Disease Using Candidate Genes and Meta-analysis of Association Studies. Annals of Human Genetics 70:2, 145
  4. Christine Finn, Jordan Smoller. (2006) Genetic Counseling in Psychiatry. Harvard Review of Psychiatry 14:2, 109
    M.J.E. Rijn, C.M. Duijn, A.J.C. Slooter. (2005) The impact of genetic testing on complex diseases. European Journal of Epidemiology 20:5, 383
  5. Guillermo J. Ruiz-Argüelles, Briceida López-Martínez, Patricia Valdés-Tapia, J. David Gómez-Rangel, Virginia Reyes-Núñez, Javier Garcés-Eisele. (2005) Primary thrombophilia in Mexico. V. A comprehensive prospective study indicates that most cases are multifactorial. American Journal of Hematology 78:1, 21
  6. Christopher E. Aston, David A. Ralph, Dominique P. Lalo, Sharmila Manjeshwar, Bobby A. Gramling, Daniele C. DeFreese, Amy D. West, Dannielle E. Branam, Linda F. Thompson, Melissa A. Craft. (2005) Oligogenic combinations associated with breast cancer risk in women under 53 years of age. Human Genetics 116:3, 208
  7. Julian Little, Linda Sharp, Muin J Khoury, Linda Bradley, Marta Gwinn. (2005) The Epidemiologic Approach to Pharmacogenomics. American Journal of PharmacoGenomics 5:1, 1
  8. Frank Geller, Kathrin Reichwald, Astrid Dempfle, Thomas Illig, Caren Vollmert, Stephan Herpertz, Winfried Siffert, Matthias Platzer, Claudia Hess, Thomas Gudermann, Heike Biebermann, H.‐Erich Wichmann, Helmut Schäfer, Anke Hinney, and Johannes Hebebrand . (2004) Melanocortin‐4 Receptor Gene Variant I103 Is Negatively Associated with Obesity. The American Journal of Human Genetics 74:3, 572-581
    Online publication date: 1-Jan-2004
  9. A. Cecile J. W. Janssens, M. Carolina Pardo, Ewout W. Steyerberg, and Cornelia M. van Duijn . (2004) Revisiting the Clinical Validity of Multiplex Genetic Testing in Complex Diseases. The American Journal of Human Genetics 74:3, 585-588
    Online publication date: 1-Jan-2004.
  10. Quanhe Yang, Muin J. Khoury, Lorenzo Botto, J. M. Friedman, and W. Dana Flanders . (2004) Revisiting the Clinical Validity of Multiplex Genetic Testing in Complex Diseases: Reply to Janssens et al.. The American Journal of Human Genetics 74:3, 588-589
    Online publication date: 1-Jan-2004.
  11. Susan Treloar, Sandra Taylor, Margaret Otlowski, Kristine Barlow-Stewart, Mark Stranger, Kellie Chenoweth. (2004) Methodological Considerations in the Study of Genetic Discrimination. Community Genetics 7:4, 161
  12. Dyfrig A Hughes, F Javier Vilar, Charlotte C Ward, Ana Alfirevic, B Kevin Park, Munir Pirmohamed. (2004) Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity. Pharmacogenetics 14:6, 335
  13. Maria R. De Miglio, Rosa M. Pascale, Maria M. Simile, Maria R. Muroni, Patrizia Virdis, Kelvin M.-T. Kwong, Leslie K.L. Wong, Giovanni M. Bosinco, Franca R. Pulina, Diego F. Calvisi. (2004) Polygenic control of hepatocarcinogenesis in Copenhagen × F344 rats. International Journal of Cancer 111:1, 9
  14. Ronald JA Trent, Bing Yu, Melody Caramins. (2004) Challenges for clinical genetic DNA testing. Expert Review of Molecular Diagnostics 4:2, 201
  15. W. Dana Flanders, Muin J. Khoury, Quanhe Yang, Marta Gwinn, Julian Little. (2004) An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genetics in Medicine 6:1, 38
  16. C. M. Duijn. (2004) Prospects of genetic research of mild cognitive impairment. Journal of Internal Medicine 256:3, 235
  17. Charles J. Epstein. (2004) Genetic testing: Hope or hype?. Genetics in Medicine 6:4, 165
  18. R. J. F. Loos, C. Bouchard. (2003) Obesity - is it a genetic disorder?. Journal of Internal Medicine 254:5, 401
  19. Muin J. Khoury. (2003) Genetics and genomics in practice: The continuum from genetic disease to genetic information in health and disease. Genetics in Medicine 5:4, 261
Page last reviewed: January 15, 2008 (archived document)
Content Source: National Office of Public Health Genomics